Keyphrases
Randomized Controlled Trial
100%
Subgroup Analysis
100%
New Intervention
100%
Plan Implementation
100%
Resource Allocation
50%
Trial Population
50%
Transportability
50%
Public Health
25%
AIDS/HIV
25%
Cost-effectiveness Analysis
25%
Pre-exposure Prophylaxis (PrEP)
25%
External Validity
25%
Number-needed-to-treat
25%
Resource Cost
25%
Multiple Countries
25%
Subgroup Effects
25%
Effect Estimates
25%
Profilaxis
25%
Medicine and Dentistry
Randomized Controlled Trial
100%
Subgroup Analysis
100%
Cost-Effectiveness Analysis
25%
Human Immunodeficiency Virus
25%
Population Research
25%
Public Health
25%
Numbers Needed to Treat
25%
Biochemistry, Genetics and Molecular Biology
Randomized Controlled Trial
100%
Population Research
50%
Human Immunodeficiency Virus
50%
Number Needed to Treat
50%
Agricultural and Biological Sciences
Resource Allocation
100%
Human Immunodeficiency Virus
50%
Nutrition Policy
50%
Psychology
Resource Allocation
100%
Public Health
50%
Neuroscience
Randomized Controlled Trial
100%
Human Immunodeficiency Virus
50%